Brian W. Pack

405 total citations
22 papers, 284 citations indexed

About

Brian W. Pack is a scholar working on Spectroscopy, Analytical Chemistry and Molecular Biology. According to data from OpenAlex, Brian W. Pack has authored 22 papers receiving a total of 284 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Spectroscopy, 9 papers in Analytical Chemistry and 4 papers in Molecular Biology. Recurrent topics in Brian W. Pack's work include Analytical Chemistry and Chromatography (7 papers), Mass Spectrometry Techniques and Applications (5 papers) and Computational Drug Discovery Methods (3 papers). Brian W. Pack is often cited by papers focused on Analytical Chemistry and Chromatography (7 papers), Mass Spectrometry Techniques and Applications (5 papers) and Computational Drug Discovery Methods (3 papers). Brian W. Pack collaborates with scholars based in United States, United Kingdom and Switzerland. Brian W. Pack's co-authors include Donald S. Risley, Gary M. Hieftje, Steven W. Baertschi, Evan M. Hetrick, J. A. C. Broekaert, John P. Guzowski, Li Liu, Todd J. Page, Marvin M. Hansen and Qinhan Jin and has published in prestigious journals such as Analytical Chemistry, Journal of Chromatography A and Analytica Chimica Acta.

In The Last Decade

Brian W. Pack

21 papers receiving 271 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Brian W. Pack United States 11 159 133 76 51 24 22 284
K. S. Lakshmi India 11 119 0.7× 158 1.2× 41 0.5× 32 0.6× 16 0.7× 35 330
Hisham Hashem Egypt 14 277 1.7× 292 2.2× 81 1.1× 59 1.2× 13 0.5× 42 468
Ida Fejős Hungary 12 241 1.5× 75 0.6× 165 2.2× 46 0.9× 23 1.0× 18 342
Lajos Attila Papp Romania 14 239 1.5× 79 0.6× 152 2.0× 44 0.9× 19 0.8× 24 367
Sonia T. Hassib Egypt 13 120 0.8× 196 1.5× 32 0.4× 43 0.8× 10 0.4× 30 344
Nehal F. Farid Egypt 12 157 1.0× 208 1.6× 29 0.4× 58 1.1× 11 0.5× 43 352
Niveen A. Mohamed Egypt 12 203 1.3× 244 1.8× 100 1.3× 90 1.8× 15 0.6× 31 504
Robert J. Markovich United States 15 253 1.6× 142 1.1× 80 1.1× 152 3.0× 35 1.5× 21 436
Douglas Both United States 9 55 0.3× 94 0.7× 97 1.3× 81 1.6× 54 2.3× 16 319
Mel Koch United States 9 128 0.8× 254 1.9× 185 2.4× 80 1.6× 10 0.4× 12 478

Countries citing papers authored by Brian W. Pack

Since Specialization
Citations

This map shows the geographic impact of Brian W. Pack's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Brian W. Pack with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Brian W. Pack more than expected).

Fields of papers citing papers by Brian W. Pack

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Brian W. Pack. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Brian W. Pack. The network helps show where Brian W. Pack may publish in the future.

Co-authorship network of co-authors of Brian W. Pack

This figure shows the co-authorship network connecting the top 25 collaborators of Brian W. Pack. A scholar is included among the top collaborators of Brian W. Pack based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Brian W. Pack. Brian W. Pack is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Pack, Brian W., Robert W. Siegel, Paul D. Cornwell, et al.. (2025). A Phase-Appropriate Risk Assessment Strategy in Support of the Safety of Peptide and Oligonucleotide-Related Impurities. The AAPS Journal. 27(2). 56–56. 3 indexed citations
2.
Pack, Brian W., et al.. (2025). Therapeutic Peptides Control Strategy: Perspective on Current Industry Practices. Organic Process Research & Development. 29(2). 270–280. 3 indexed citations
3.
Hetrick, Evan M., et al.. (2024). Mass balance analysis for therapeutic peptides: Case studies, applications, and perspectives. Journal of Pharmaceutical and Biomedical Analysis. 252. 116501–116501.
4.
Pack, Brian W., et al.. (2017). Development of an in vivo -relevant drug product performance method for an amorphous solid dispersion. Journal of Pharmaceutical and Biomedical Analysis. 142. 307–314. 7 indexed citations
5.
Gorman, Gregory S., et al.. (2016). Best Practices in Stability Indicating Method Development and Validation for Non-clinical Dose Formulations. The AAPS Journal. 18(6). 1418–1423. 4 indexed citations
6.
Pack, Brian W., et al.. (2015). Modernization of Physical Appearance and Solution Color Tests Using Quantitative Tristimulus Colorimetry: Advantages, Harmonization, and Validation Strategies. Journal of Pharmaceutical Sciences. 104(10). 3299–3313. 11 indexed citations
7.
Strege, Mark A., Evan M. Hetrick, Allison L. Dill, et al.. (2015). Assessing the Risk of Formation of Potential Genotoxic Degradation Products in a Small-Molecule Kinase Inhibitor Drug Substance and Drug Product. Organic Process Research & Development. 19(11). 1458–1464. 4 indexed citations
8.
Cannady, Ellen A., Aktham Aburub, Chris Ward, et al.. (2015). Absolute bioavailability of evacetrapib in healthy subjects determined by simultaneous administration of oral evacetrapib and intravenous [13C8]‐evacetrapib as a tracer. Journal of Labelled Compounds and Radiopharmaceuticals. 59(6). 238–244. 12 indexed citations
9.
Hansen, Marvin M., et al.. (2013). The Assessment of Impurities for Genotoxic Potential and Subsequent Control in Drug Substance and Drug Product. Journal of Pharmaceutical Sciences. 102(5). 1404–1418. 31 indexed citations
10.
Hetrick, Evan M., et al.. (2013). Integrating Tristimulus Colorimetry into Pharmaceutical Development for Color Selection and Physical Appearance Control: A Quality-by-Design Approach. Journal of Pharmaceutical Sciences. 102(8). 2608–2621. 18 indexed citations
11.
Baertschi, Steven W., et al.. (2013). Assessing mass balance in pharmaceutical drug products: New insights into an old topic. TrAC Trends in Analytical Chemistry. 49. 126–136. 16 indexed citations
12.
Liao, Kristine, et al.. (2007). The effect of analyte acidity on signal suppression and the implications to peak purity determinations using atmospheric pressure ionization mass spectrometry. Journal of Pharmaceutical and Biomedical Analysis. 44(1). 118–126. 5 indexed citations
13.
Risley, Donald S. & Brian W. Pack. (2006). Simultaneous determination of positive and negative counterions using a hydrophilic interaction chromatography method. LCGC North America. 24(8). 82–90. 8 indexed citations
14.
Liu, Li & Brian W. Pack. (2006). Cleaning verification assays for highly potent compounds by high performance liquid chromatography mass spectrometry: Strategy, validation, and long-term performance. Journal of Pharmaceutical and Biomedical Analysis. 43(4). 1206–1212. 13 indexed citations
16.
Pack, Brian W., Gary M. Hieftje, & Qinhan Jin. (1999). Use of an air/argon microwave plasma torch for the detection of tetraethyllead. Analytica Chimica Acta. 383(3). 231–241. 13 indexed citations
17.
Pack, Brian W., et al.. (1998). A heated transfer line for coupling GC with plasma source spectrometry. 30(21). 2 indexed citations
18.
Pack, Brian W., et al.. (1998). Evaluation of Ultrasonic Nebulization for the Analysis of Transient Samples: A Theoretical Model and Practical Considerations. Applied Spectroscopy. 52(12). 1515–1521. 13 indexed citations
19.
Pack, Brian W. & Gary M. Hieftje. (1997). An improved microwave plasma torch for atomic spectrometry. Spectrochimica Acta Part B Atomic Spectroscopy. 52(14). 2163–2168. 14 indexed citations
20.
Harrington, Peter de B. & Brian W. Pack. (1993). FLIN: Fuzzy linear interpolating network. Analytica Chimica Acta. 277(2). 189–197. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026